Bela Mehta
Amgen (United States)(US)
Publications by Year
Research Areas
Immune Cell Function and Interaction, Immune Response and Inflammation, CAR-T cell therapy research, T-cell and B-cell Immunology, Immunotherapy and Immune Responses
Most-Cited Works
- Phenotypic characterization and identification of effector cells involved in tumor cell recognition of cytokine-induced killer cells.(1993)
- → Role of elevated monocyte transforming growth factor? (TGF?) production in posttrauma immunosuppression(1991)109 cited
- → Expansion of Philadelphia Chromosome–Negative CD3+CD56+ Cytotoxic Cells From Chronic Myeloid Leukemia Patients: In Vitro and In Vivo Efficacy in Severe Combined Immunodeficiency Disease Mice(1998)109 cited
- → Sensitivity of Multidrug-Resistant Tumor Cell Lines to Immunologic Effector Cells(1996)87 cited
- → Simultaneous detection of DNA synthesis and cytokine production in staphylococcal enterotoxin B activated CD4+ T lymphocytes by flow cytometry(1997)54 cited
- → The Role of N-Linked Carbohydrate Residues in Lymphokine-Activated Killer Cell-Mediated Cytolysis(1994)11 cited
- → Interactions of Immunopathological Mediators (Tumor Necrosis Factor-α, TGF-β, Prostaglandin E2) in Traumatized Individuals(1993)9 cited
- → Non-Hodgkin’s Lymphoma: Natural Cell-Mediated Cytotoxicity Correlated with Histological Classification and Prognosis(1989)5 cited
- → Book Reviews(1989)
- → P3.12E.05 Real-World Comparative Effectiveness of Sotorasib vs Docetaxel as 2L/2L+ Treatment of KRAS G12c-Mutated Advanced NSCLC(2024)